文献速递系统性红斑狼疮

SLE-DAS可实现准确且易用的临床缓解与疾病活动度分类定义

Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) enables accurate and user-friendly definitions of clinical remission and categories of disease activity.
PubMed 文献 · Ann Rheum Dis · 2021-08-18

该研究在Padova队列推导SLE-DAS的疾病活动度分类和临床缓解定义,并在Cochin队列和BLISS-76试验中验证。推导出的切点为:缓解SLE-DAS≤2.08,轻度活动2.08<SLE-DAS≤7.64,中重度活动SLE-DAS>7.64;验证中敏感度和特异度均较高,SLE-DAS是准确且易用的工具。

要点

  • SLE-DAS切点:缓解≤2.08,轻度2.08-7.64,中重度>7.64
  • Cochin队列验证敏感度和特异度均较高
  • SLE-DAS基于布尔和指数的缓解定义敏感度100%、特异度>97%

核心结论

  • SLE-DAS是定义SLE临床缓解状态和疾病活动度分类的准确且易用工具,已针对专家评估和BILAG进行验证。

研究设计与样本

  • 推导在意大利Padova狼疮门诊进行,验证在法国Cochin狼疮门诊前瞻性开展并对BLISS-76试验进行事后分析。
  • 共纳入1190例SLE患者:推导队列221例,验证队列969例(Cochin 150例;BLISS-76 819例)。
  • 使用受试者工作特征曲线分析在Padova队列推导SLE-DAS切点,在Cochin队列以专家分类、在BLISS-76以BILAG指数评估性能。
  • 临床缓解状态的金标准为满足SLE缓解定义(Definition Of Remission In SLE),布尔和指数缓解定义由卡方自动交互检测算法支持。
  • 开发并测试了SLE-DAS在线计算器。

主要发现

  • 推导出的切点为:缓解SLE-DAS≤2.08;轻度活动2.08<SLE-DAS≤7.64;中重度活动SLE-DAS>7.64。
  • 在Cochin队列验证中,缓解、轻度和中重度活动的敏感度和特异度分别高于90%、82%和95%。
  • SLE-DAS布尔型和指数型缓解定义的敏感度为100%,特异度高于97%。

关键数值与推荐

  • 缓解:SLE-DAS≤2.08;轻度活动:2.08<SLE-DAS≤7.64;中重度活动:SLE-DAS>7.64。
  • Cochin队列验证:缓解敏感度和特异度均>90%;轻度活动敏感度和特异度均>82%;中重度活动敏感度和特异度均>95%。
  • SLE-DAS布尔型和指数型缓解定义:敏感度100%,特异度>97%。

临床怎么用

  • 临床可使用SLE-DAS切点将SLE患者分类为缓解、轻度活动或中重度活动,辅助疾病活动度评估和缓解判断。
  • SLE-DAS在线计算器已开发并测试,便于临床使用。

局限性

  • 验证主要基于Cochin队列和BLISS-76试验的事后分析,需进一步在前瞻性多中心队列中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: There is an unmet need for accurate and user-friendly definitions of systemic lupus erythematosus (SLE) disease activity and remission. We aimed to derive and validate the SLE Disease Activity Score (SLE-DAS) definitions for disease activity categories and clinical remission state. METHODS: Derivation was conducted at Padova Lupus Clinic (Italy). Validation was prospectively performed at Cochin Lupus Clinic (France) and by post hoc analysis of BLISS-76 trial. At each clinic, an expert classified patients in three categories: remission, mild or moderate/severe activity. The SLE-DAS cut-offs were derived using the receiver operating characteristic curve analysis in Padova cohort; its performance was assessed against expert classification in Cochin cohort and British Isles Lupus Assessment Group (BILAG) index in BLISS-76. Gold standard for clinical remission state was the fulfilment of Definition Of Remission In SLE. A Boolean and an index-based definitions of remission were sustained by chi-square automatic interaction detection algorithm. An SLE-DAS online calculator was developed and tested. RESULTS: We included 1190 patients with SLE: 221 in the derivation cohort and 969 in the validation cohorts (150 from Cochin; 819 from BLISS-76). Derived cut-offs were: remission, SLE-DAS ≤2.08; mild activity, 2.08<SLE-DAS≤7.64; moderate/severe activity, SLE-DAS >7.64. Regarding validation in Cochin cohort, sensitivity and specificity are above 90%, 82% and 95% for remission, mild and moderate/severe activity, respectively. The SLE-DAS Boolean-based and index-based remission showed sensitivity of 100% and specificity above 97%. CONCLUSION: The SLE-DAS is an accurate and easy-to-use tool for defining SLE clinical remission state and disease activity categories, validated against expert assessment and BILAG.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Jesus D, Larosa M, Henriques C, et al. Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) enables accurate and user-friendly definitions of clinical remission and categories of disease activity. Ann Rheum Dis. 2021. PMID: 34407927. doi:10.1136/annrheumdis-2021-220363

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。